Senate Files

Bills

S. 864 119th Congress

HELP Copays Act

Latest action, Mar 19, 2026: Committee on Health, Education, Labor, and Pensions. Hearings held.

How the Senate voted

The Senate hasn't taken a roll call on this bill in the Congresses covered.

28 cosponsors

Sponsored by Roger Marshall (Republican). Cosponsors by party, House members included:

  • Democrats
  • Republicans
  • Independents
Cosponsors
21 D · 7 R
  • Democrat
  • Republican
  • Independent
28 senators cosponsoring

Referred to: Senate: Health, Education, Labor, and Pensions Committee

Who lobbied on it

Clients whose quarterly lobbying reports named it, each quarter.

38 clientsQ1 2025Q3 2026

The clients with the most reports naming it. A report's amount covers all of that client's lobbying in the quarter, not just this bill.

ABBVIE INC.
7 reports
AMERICA'S HEALTH INSURANCE PLANS INC (AHIP)
7 reports
AMERICAN ACADEMY OF OPHTHALMOLOGY
7 reports
AMERICAN BANKERS ASSOCIATION
SPANGLER STRATEGIES LLC
7 reports
AMERICAN COLLEGE OF RHEUMATOLOGY
7 reports
ARTHRITIS FOUNDATION
7 reports
ASSOCIATION FOR CLINICAL ONCOLOGY
7 reports
CYSTIC FIBROSIS FOUNDATION
7 reports
EMD SERONO INC
7 reports
EMD SERONO INC.
TODD STRATEGY GROUP
7 reports
EPILEPSY FOUNDATION
7 reports
GSK (FKA GLAXOSMITHKLINE INC.)
7 reports
JOHNSON & JOHNSON SERVICES INC
7 reports
JOHNSON & JOHNSON SERVICES, INC.
TODD STRATEGY GROUP
7 reports
NOVARTIS
7 reports
All 25 of 49 clients
ClientLobbying firmReportsReports totalingFromToSenate
ABBVIE INC.7$9.9MQ1 2025Q3 2026yes
AMERICA'S HEALTH INSURANCE PLANS INC (AHIP)7$28.6MQ1 2025Q3 2026yes
AMERICAN ACADEMY OF OPHTHALMOLOGY7$2.1MQ1 2025Q3 2026yes
AMERICAN BANKERS ASSOCIATIONSPANGLER STRATEGIES LLC7$0Q1 2025Q3 2026yes
AMERICAN COLLEGE OF RHEUMATOLOGY7$610KQ1 2025Q3 2026yes
ARTHRITIS FOUNDATION7$525KQ1 2025Q3 2026yes
ASSOCIATION FOR CLINICAL ONCOLOGY7$1.9MQ1 2025Q3 2026yes
CYSTIC FIBROSIS FOUNDATION7$1.4MQ1 2025Q3 2026yes
EMD SERONO INC7$5.4MQ1 2025Q3 2026yes
EMD SERONO INC.TODD STRATEGY GROUP7$0Q1 2025Q3 2026yes
EPILEPSY FOUNDATION7$670KQ1 2025Q3 2026yes
GSK (FKA GLAXOSMITHKLINE INC.)7$8.9MQ1 2025Q3 2026yes
JOHNSON & JOHNSON SERVICES INC7$15.5MQ1 2025Q3 2026yes
JOHNSON & JOHNSON SERVICES, INC.TODD STRATEGY GROUP7$0Q1 2025Q3 2026yes
NOVARTIS7$14.0MQ1 2025Q3 2026yes
PHARMACEUTICAL CARE MANAGEMENT ASSOCIATIONEMERGENT STRATEGIES7$0Q1 2025Q3 2026yes
SANOFI US SERVICES INC7$11.0MQ1 2025Q3 2026yes
THE ALS ASSOCIATION7$210KQ1 2025Q3 2026yes
UCB, INC.THE NICKLES GROUP, LLC7$450KQ1 2025Q3 2026yes
VERTEX PHARMACEUTICALS INCORPORATED7$8.4MQ1 2025Q3 2026yes
MERCK & CO., INC.TODD STRATEGY GROUP6$0Q1 2025Q2 2026yes
NATIONAL BLEEDING DISORDER FOUNDATION (FKA NATIONAL HEMOPHILIA FOUNDATION)ARTEMIS POLICY GROUP LLC6$300KQ4 2025Q3 2026yes
PATIENT ACCESS NETWORK FOUNDATIONVENABLE LLP6$240KQ1 2025Q2 2026yes
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICATODD STRATEGY GROUP6$0Q1 2025Q2 2026yes
THE HS COALITIONTHE KPM GROUP DC LLC6$340KQ4 2025Q3 2026yes